Research Article - (2015) Volume 18, Issue 5

A Post-Authorisation Safety Survey Evaluating Risperidone Long-Acting Injectable in Romania

Ioana Micluţia1*, Ramona Pãunescu1 and Roxana Ciungu2
1Department of Neurosciences, discipline of Psychiatry and Paediatric Psychiatry, Iuliu Hatieganu University of Medicine and Pharmacy, Emergency County Hospital Cluj, Second Psychiatric Clinic, Cluj-Napoca, Romania
2Medical Affairs, Janssen, Division of Johnson and Johnson Romania, Bucharest, Romania
*Corresponding Author: